Home › Funds › Marex Group Ltd › HIMS
Marex Group Ltd position in HIMS
HIMS & HERS HEALTH INC · Health Care
Marex Group Ltd reported holding 973,771 shares of HIMS (HIMS & HERS HEALTH INC) in its Q2 2026 13F filing — a position valued at US$33.8M, representing 0.43% of its reported portfolio and ranking #49 among its reported holdings. Marex Group Ltd has disclosed HIMS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Marex Group Ltd's HIMS position evolved
Marex Group Ltd first disclosed a stake in HIMS in Q2 2024 at 105,000 shares (US$2.1M). The position peaked in Q4 2025 at 2,419,518 shares, worth US$78.6M. Across 9 filings, Marex Group Ltd increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 973,771 shares valued at US$33.8M — a reduction of -365,043 shares quarter over quarter.. Notable position changes include a 2543% increase in Q1 2025 (shares rose 69% over the following quarter), a 233% increase in Q2 2025 (shares rose 14% over the following quarter), a 162% increase in Q4 2025 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 105.00K | $2.12M | New |
| Q3 2024 | 105.91K | $1.95M | Add |
| Q4 2024 | 12.29K | $297.12K | Reduce |
| Q1 2025 | 324.75K | $9.60M | Add |
| Q2 2025 | 1.08M | $53.63M | Add |
| Q3 2025 | 922.81K | $52.34M | Reduce |
| Q4 2025 | 2.42M | $78.56M | Add |
| Q1 2026 | 1.34M | $27.79M | Reduce |
| Q2 2026 | 973.77K | $33.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HIMS and 13F data
HIMS (HIMS & HERS HEALTH INC) is a Health Care company. 34 other funds we track also report a position in HIMS — the largest reported positions include Divisadero Street Capital Management, LP (US$208.3M), Bienville Capital Management, LLC (US$27.2M), Foresite Capital Management V, LLC (US$25.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HIMS
- Divisadero Street Capital Management, LP 6.01M sh · $208.35M · Q2 2026
- Bienville Capital Management, LLC 785.74K sh · $27.24M · Q2 2026
- Foresite Capital Management V, LLC 738.15K sh · $25.59M · Q2 2026
More on Marex Group Ltd
FAQ
How long has Marex Group Ltd held HIMS?
Marex Group Ltd has disclosed HIMS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Marex Group Ltd's current position in HIMS?
As of Q2 2026, Marex Group Ltd holds 973.77K shares of HIMS (HIMS & HERS HEALTH INC), valued at $33.76M, representing 0.43% of its reported portfolio and ranking #49.
Has Marex Group Ltd been buying or selling HIMS?
In the latest 13F filing (Q2 2026), Marex Group Ltd reduced its position in HIMS. The position peaked in Q4 2025 at 2.42M shares.
Which other funds hold HIMS?
Other major institutional holders of HIMS include Divisadero Street Capital Management, LP, Bienville Capital Management, LLC, Foresite Capital Management V, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.